💊 GSK drug meets a ban in China; A new malaria antibody works

#206 | Coming soon: flights to the moon

Hello, and welcome back to The Kable. It's been a quiet start to November, possibly because everybody is already planning for 2023.

In Indonesia, authorities have revoked the fever syrup licenses of the two drugmakers whose cough syrups have led to over 150 deaths. And The Gambia, where the intense focus on paediatric cough syrups originated, says it has not yet been confirmed that the child deaths were due to consuming cough syrup.

The Nigeria CDC has said Nigeria is at high risk of an Ebola outbreak from neighbouring Uganda. The agency has issued a public health advisory warning people against non-essential travel to Uganda.

And another chapter in the ongoing "brain drain" saga in Nigeria. President Muhammadu Buhari needed a medical checkup. We assume he insisted on being checked by Nigerian healthcare professionals, which is why he is in the UK for a checkup.

Elsewhere, J&J's Janssen was looking to recruit patients for a Phase 1 clinical prostate cancer treatment trial in partnership with Canada's ESSA Pharma. However, the company has now called off the trial because it couldn't find more than three patients.